Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+4.0%
5Y CAGR+10.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.0%/yr
vs +41.2%/yr prior
5Y CAGR
+10.5%/yr
Recent deceleration
Acceleration
-37.1pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $109.16M | -35.5% |
| 2024 | $169.31M | +32.5% |
| 2023 | $127.80M | +31.8% |
| 2022 | $96.94M | +25.0% |
| 2021 | $77.55M | +17.2% |
| 2020 | $66.19M | +39.8% |
| 2019 | $47.35M | +94.0% |
| 2018 | $24.41M | +68.1% |
| 2017 | $14.53M | - |